Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923805 · ClinicalTrials.gov registry record · NA
Vitagel Revision Total Knee Arthroplasty
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01923805 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 8 participants.
The verdict
NCT01923805, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This prospective study will evaluate the effectiveness of Vitagel (VG) in reducing blood loss associated with Revision Total Knee Arthroplasty (RTKA) procedures by assessing the patient's change in hemoglobin/hematocrit. Transfusion rates with the use of VG compared to the current standard of care will also be evaluated. The effectiveness of VG to potentially reduce pain, and increase return to function and quality of life will be assessed through the modified Knee Injury and Osteoarthritis Outcome Score (Modified KOOS), the Numerical Assessment Pain Scale (NAPS), and the SF-12 health survey. Analgesic use will be recorded post-operatively.
Interventions
- DEVICE Vitagel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01923805
The ClinicalTrials.gov registry entry for NCT01923805 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitagel is the first listed.
NCT01923805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01923805 about?
NCT01923805 is a clinical study titled "Vitagel Revision Total Knee Arthroplasty". This prospective study will evaluate the effectiveness of Vitagel (VG) in reducing blood loss associated with Revision Total Knee Arthroplasty (RTKA) procedures by assessing the patient's change in hemoglobin/hematocrit. Transfusion rates with the use of VG compared to the current standard of care w...
What is the current status of trial NCT01923805?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2013-04. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01923805?
The interventions under investigation include: Vitagel (DEVICE).
Who is sponsoring clinical trial NCT01923805?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.